PTC Therapeutics, Inc. (PTCT) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ptc Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.416 Ladies and gentlemen, thank you for standing by. 00:00:02.416 -- 00:00:07.987 Welcome to PTC Therapeutics' third quarter 2025 earnings conference call. 00:00:07.987 -- 00:00:12.596 All participants are in listen-only mode. After the presentation, there will be a Q&A 00:00:12.596 -- 00:00:16.463 session. Today's call is being recorded. 00:00:16.463 -- 00:00:20.852 I would now like to turn the call over to Ellen Cavallari, Head of Investor Relations. 00:00:20.852 -- 00:00:23.252 Please go ahead. 00:00:23.470 -- 00:00:28.378 Good afternoon, and thank you for joining us to discuss PTC Therapeutics' third quarter 00:00:28.378 -- 00:00:32.024 2025 corporate update and financial results. 00:00:32.024 -- 00:00:34.668 I'm joined today by our Chief Executive Officer, Dr. 00:00:34.668 -- 00:00:39.736 Matthew Klein, our Chief Business Officer, Eric Powell, and our Chief Financial Officer, 00:00:39.736 -- 00:00:44.503 Pierre Gravier. Today's call will include forward-looking statements based on our current 00:00:44.503 -- 00:00:49.611 expectations. These statements are subject to certain risks and uncertainties, and actual 00:00:49.611 -- 00:00:54.422 results may differ materially. Please review the slide posted on our investor relations 00:00:54.422 -- 00:00:58.668 website in conjunction with the call, which contains information about our forward-looking 00:00:58.668 -- 00:01:03.835 statements, our most recent quarterly report on Form 10Q, and annual report 00:01:03.835 -- 00:01:08.942 on Form 10K filed with the SEC, as well as our other SEC filings for a detailed 00:01:08.942 -- 00:01:13.368 description of applicable risks and uncertainties that could cause our actual performance 00:01:13.368 -- 00:01:17.734 and results to differ materially f...